Amgen Inc.
AMGN
$305.70
-$1.22-0.40%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 8.50% | 4.52% | 2.91% | 1.96% | 2.07% |
| Total Other Revenue | -15.90% | -33.48% | -29.03% | -32.23% | -9.51% |
| Total Revenue | 7.09% | 1.91% | 0.75% | -0.48% | 1.32% |
| Cost of Revenue | 31.91% | 11.10% | 7.35% | 0.61% | -0.74% |
| Gross Profit | -0.89% | -1.03% | -1.36% | -0.84% | 2.01% |
| SG&A Expenses | 13.89% | 3.74% | 2.38% | 1.91% | 0.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 22.71% | -92.22% | -88.44% | 18,166.67% | 18,100.00% |
| Total Operating Expenses | 19.29% | 2.97% | -0.38% | 2.45% | 0.94% |
| Operating Income | -14.43% | 0.09% | 2.79% | -5.55% | 2.01% |
| Income Before Tax | 6.93% | 13.22% | 22.74% | 39.79% | 9.63% |
| Income Tax Expenses | 43.32% | 32.55% | 32.86% | 50.25% | -1.73% |
| Earnings from Continuing Operations | 2.52% | 10.69% | 21.34% | 38.34% | 11.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.52% | 10.69% | 21.34% | 38.34% | 11.18% |
| EBIT | -14.43% | 0.09% | 2.79% | -5.55% | 2.01% |
| EBITDA | -5.56% | 1.94% | 3.41% | -3.51% | 1.63% |
| EPS Basic | 3.15% | 12.86% | 25.87% | 45.11% | 17.53% |
| Normalized Basic EPS | -7.46% | 15.12% | 13.99% | 15.66% | -8.25% |
| EPS Diluted | 3.23% | 12.78% | 25.62% | 44.72% | 17.40% |
| Normalized Diluted EPS | -7.52% | 14.95% | 13.80% | 15.53% | -8.26% |
| Average Basic Shares Outstanding | -0.65% | -1.88% | -3.30% | -4.93% | -5.53% |
| Average Diluted Shares Outstanding | -0.55% | -1.78% | -3.19% | -4.86% | -5.54% |
| Dividend Per Share | 9.79% | 9.89% | 10.00% | 10.11% | 10.23% |
| Payout Ratio | 0.06% | -0.03% | -0.13% | -0.25% | -0.06% |
